- 아토피성 피부염 환자의 성상신경절 차단 -증례보고-
- ㆍ 저자명
- 김성곤,이규창,강포순,우남식,이예철,Kim. Seong-Kon,Lee. Kyu-Chang,Kang. Po-Sun,Woo. Nam-Sik,Lee. Ye-Chul
- ㆍ 간행물명
- 大韓痛症學會誌
- ㆍ 권/호정보
- 1995년|8권 1호|pp.124-126 (3 pages)
- ㆍ 발행정보
- 대한통증학회
- ㆍ 파일정보
- 정기간행물| PDF텍스트
- ㆍ 주제분야
- 기타
Atopic allergy implies a familial tendency to manifest alone or in combination such as asthma, rhinitis, urticaria and atopic dermatitis. The patient with atopic dermatitis shows a variety of humoral and cell-mediated immune dysfunction, including an elevation of serum IgE level, multiple positive immediate skin tests to a variety of antigen. A 30 year old female patient suffering from an atopic dermatitis on face, has been administered a stellate ganglion block(SGB) with a 1% mepivacaine 5cc. She complained of bronchial hyperresponsivness such as cough, soreness, and inspiration difficulty for 5 days following the treatment, so we have reduced 1% mepivacaine dose from 5cc to 3cc. She had no complain of bronchial hyperresponsivenss and the lesion of atopic dermatitis was improved. From our result we conclude that SGB appears to be a good choice for the treatment of the atopic dermatitis and only 1% mepivacaine 3cc is possible in complete SGB.